Literature DB >> 31844145

Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis.

Diego Adrianzen Herrera1, Kith Pradhan2, Rose Snyder3, Siddharth Karanth4, Murali Janakiram5, Ioannis Mantzaris3, Ira Braunschweig3, Anjali Budhathoki3, Urvi A Shah6, Amit K Verma3, Santosh B Murthy7, Aditi Shastri8.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31844145     DOI： 10.1038/s41375-019-0673-8

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Authors:  Joan L Warren; Carrie N Klabunde; Deborah Schrag; Peter B Bach; Gerald F Riley
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

2.  Cause of death in patients with lower-risk myelodysplastic syndrome.

Authors:  Farshid Dayyani; Anthony P Conley; Sara S Strom; William Stevenson; Jorge E Cortes; Gautam Borthakur; Stefan Faderl; Susan O'Brien; Sherry Pierce; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860
  2 in total
  3 in total

1.  Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry-based cohort study.

Authors:  Konstantinos Liapis; Georgios Vrachiolias; Vasileios Papadopoulos; Alexandra Kourakli; Athanasios G Galanopoulos; Menelaos Papoutselis; Sotirios G Papageorgiou; Panagiotis T Diamantopoulos; Vassiliki Pappa; Nora-Athina Viniou; Theodoros P Vassilakopoulos; Eleftheria Hatzimichael; Eleni Bouronikou; Maria Ximeri; Charalambos Pontikoglou; Panayiotis Panayiotidis; Stamatis Karakatsanis; Anna Vardi; Argiris Symeonidis; Ioannis Kotsianidis
Journal:  EJHaem       Date:  2020-07-01

Review 2.  New Approaches to Myelodysplastic Syndrome Treatment.

Authors:  Alexandre Bazinet; Guillermo Montalban Bravo
Journal:  Curr Treat Options Oncol       Date:  2022-03-23

3.  Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia.

Authors:  Lachelle D Weeks; Catherine R Marinac; Robert Redd; Gregory Abel; Amy Lin; Mridul Agrawal; Richard M Stone; Deborah Schrag; Benjamin L Ebert
Journal:  Blood       Date:  2022-02-24       Impact factor: 25.476
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.